Louis M Weiner Selected Research

Louis M Weiner Research Topics

Disease

85	Neoplasms (Cancer) 02/2024 - 01/2002
11	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 04/2003
11	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2003
10	Adenocarcinoma 02/2024 - 04/2003
6	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 11/2005
4	Fatigue 05/2015 - 10/2002
4	Carcinoma (Carcinomatosis) 05/2013 - 10/2003
3	Pathologic Complete Response 02/2024 - 02/2006
3	Fibrosis (Cirrhosis) 01/2020 - 08/2008
3	Neoplasm Metastasis (Metastasis) 12/2016 - 01/2006
3	Diarrhea 02/2008 - 10/2002
3	Neutropenia 06/2004 - 10/2002
2	Colonic Neoplasms (Colon Cancer) 02/2023 - 01/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2012 - 01/2003
2	Lymphoma (Lymphomas) 12/2012 - 05/2008
2	Carcinogenesis 04/2010 - 01/2006
2	Circulating Neoplastic Cells 04/2008 - 07/2006
2	Vomiting 02/2008 - 04/2003
2	Exanthema (Rash) 11/2005 - 04/2003
1	Melanoma (Melanoma, Malignant) 11/2021
1	Pancreatitis 01/2021
1	Injection Site Reaction 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Arthritis (Polyarthritis) 01/2020

Drug/Important Bio-Agent (IBA)

21	Monoclonal AntibodiesIBA 12/2023 - 01/2003
14	AntibodiesIBA 01/2018 - 08/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
6	Fluorouracil (Carac)FDA LinkGeneric 02/2023 - 10/2003
6	ErbB Receptors (EGF Receptor)IBA 12/2015 - 11/2005
6	AntigensIBA 11/2014 - 09/2004
5	Trastuzumab (Herceptin)FDA Link 01/2018 - 09/2005
5	Biomarkers (Surrogate Marker)IBA 04/2016 - 04/2008
4	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2018
4	Surface Antigens (Surface Antigen)IBA 06/2018 - 01/2003
4	Small Interfering RNA (siRNA)IBA 01/2017 - 09/2010
4	Immunoconjugates (Immunoconjugate)IBA 01/2015 - 01/2003
3	CytokinesIBA 11/2021 - 12/2012
3	RNA (Ribonucleic Acid)IBA 11/2021 - 06/2005
3	Gemcitabine FDA Link 01/2021 - 02/2011
3	VaccinesIBA 01/2021 - 06/2004
3	Messenger RNA (mRNA)IBA 01/2021 - 09/2011
3	Serine Proteases (Serine Protease)IBA 01/2020 - 08/2002
3	MicroRNAs (MicroRNA)IBA 03/2016 - 09/2011
3	Capecitabine (Xeloda)FDA Link 03/2016 - 02/2008
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2015 - 12/2004
3	Bispecific AntibodiesIBA 01/2015 - 12/2004
3	Radioisotopes (Radionuclides)IBA 11/2014 - 01/2003
2	ChemokinesIBA 01/2024 - 12/2012
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 11/2021 - 03/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 02/2008
2	veliparibIBA 10/2020 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 01/2017
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 03/2004
2	Lapatinib (GW572016)FDA Link 03/2016 - 12/2015
2	Phosphotransferases (Kinase)IBA 12/2015 - 12/2014
2	Tyrosine (L-Tyrosine)FDA Link 12/2015 - 03/2004
2	Growth Factor ReceptorsIBA 12/2015 - 01/2003
2	Docetaxel (Taxotere)FDA Link 05/2015 - 02/2011
2	Bortezomib (Velcade)FDA Link 06/2014 - 02/2008
2	Proteasome InhibitorsIBA 06/2014 - 02/2008
2	Epithelial Cell Adhesion MoleculeIBA 05/2013 - 07/2006
2	Single-Chain AntibodiesIBA 05/2013 - 03/2006
2	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 09/2011
2	Indicators and Reagents (Reagents)IBA 12/2012 - 03/2009
2	EpitopesIBA 03/2011 - 09/2009
2	Bevacizumab (Avastin)FDA Link 02/2011 - 09/2005
2	Cancer VaccinesIBA 04/2010 - 09/2009
2	Antineoplastic Agents (Antineoplastics)IBA 01/2008 - 04/2003
2	Cisplatin (Platino)FDA LinkGeneric 02/2006 - 10/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2006 - 10/2003
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2004 - 10/2002
2	tipifarnib (R115777)IBA 06/2004 - 04/2003
2	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2004 - 04/2003
1	Protons (Proton)IBA 09/2023
1	Chimeric Antigen ReceptorsIBA 10/2022
1	Small Cytoplasmic RNAIBA 11/2021
1	InflammasomesIBA 11/2021
1	IpilimumabIBA 11/2021
1	osteoblast cadherinIBA 01/2021
1	ruxolitinibIBA 01/2021
1	Janus KinasesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	artemisinin (artemisinine)IBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	B7-H1 AntigenIBA 01/2018
1	ArtesunateIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2018

Therapy/Procedure

55	Therapeutics 12/2023 - 01/2003
17	Immunotherapy 01/2024 - 06/2008
12	Drug Therapy (Chemotherapy) 02/2024 - 01/2003
5	Radiotherapy 02/2024 - 03/2004
2	Adjuvant Chemotherapy 01/2013 - 09/2005
2	Chemoradiotherapy 10/2007 - 02/2006
1	Neoadjuvant Therapy 02/2024
1	Proton Therapy 09/2023
1	Injections 01/2021